SAB Biotherapeutics Market Sentiment

SAB Biotherapeutics Inc

SABSNASDAQ

Trade with Public

$3.04

0.227.8%

Dern. MÀJ: Oct 22, 5:02 PM

$3.00

0.186.38%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

SAB Biotherapeutics Market Sentiment - Benzinga

SAB Biotherapeutics Market Sentiment

Market sentiment signals for SAB Biotherapeutics (SABS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 4.9% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

14 analysts

Options Flow (P/C)

0.00

More calls — Bullish

36 calls · 0 puts

Avg Consensus PT

$11

+262.0%

Highest Price Target

$16

+433.3%

Chardan Capital

Lowest Price Target

+100.0%

HC Wainwright & Co.

Short Interest

4.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Jun 24, 2026	Barclays	Eliana Merle—	+333.3%	$13	Initiate	Overweight
Jun 17, 2026	Chardan Capital	Keay Nakae—	+433.3%	$14 → $16	Maintained	Buy
Jun 15, 2026	Leerink Partners	Thomas Smith—	+300.0%	$7 → $12	Maintained	Outperform
Jun 15, 2026	HC Wainwright & Co.	Emily Bodnar—	+233.3%	$10 → $10	Maintained	Buy
May 22, 2026	Citigroup	Samantha Semenkow—	+266.7%	$11	Initiate	Buy
May 20, 2026	Jefferies	Roger Song—	+266.7%	$11	Initiate	Buy
May 12, 2026	HC Wainwright & Co.	Emily Bodnar—	+233.3%	$7 → $10	Maintained	Buy
May 11, 2026	Rodman & Renshaw	Seema Sheoran—	+333.3%	$13 → $13	Maintained	Buy
Apr 2, 2026	Rodman & Renshaw	Seema Sheoran—	+333.3%	$13	Initiate	Buy
Mar 11, 2026	Chardan Capital	Keay Nakae—	+366.7%	$12 → $14	Maintained	Buy
Mar 10, 2026	HC Wainwright & Co.	Emily Bodnar—	+133.3%	$9 → $7	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	+133.3%	$7	Initiate	Buy
Dec 19, 2025	Guggenheim	Yatin Suneja—	+400.0%	$15	Initiate	Buy
Dec 18, 2025	Chardan Capital	Keay Nakae—	+300.0%	$12 → $12	Maintained	Buy
Nov 17, 2025	Chardan Capital	Keay Nakae—	+300.0%	$12 → $12	Maintained	Buy
Sep 19, 2025	Chardan Capital	Keay Nakae—	+300.0%	$12 → $12	Maintained	Buy
Sep 17, 2025	Leerink Partners	——	+133.3%	$7	Initiate	Outperform
Aug 8, 2025	Chardan Capital	Keay Nakae—	+300.0%	$20 → $12	Maintained	Buy
Jul 22, 2025	HC Wainwright & Co.	Emily Bodnar—	+200.0%	$10 → $9	Maintained	Buy
May 15, 2025	Chardan Capital	Keay Nakae—	+566.7%	$20 → $20	Maintained	Buy
May 14, 2025	HC Wainwright & Co.	Emily Bodnar—	+233.3%	$10	Assumes	Buy
Apr 1, 2025	Chardan Capital	Keay Nakae—	+566.7%	$25 → $20	Maintained	Buy
Apr 1, 2025	HC Wainwright & Co.	Edward White—	+100.0%	$6 → $6	Maintained	Buy
Jan 29, 2025	Chardan Capital	Keay Nakae—	+733.3%	$25 → $25	Maintained	Buy
Jan 29, 2025	HC Wainwright & Co.	Edward White—	+100.0%	$6 → $6	Maintained	Buy